CN
486-73-7
Applied Filters:
Keyword:'486-73-7'
Showing 1-14 of 14 results for "486-73-7" within Technical Documents
XP725 Antibody Number-Lot Number 071M4826
-h a-b c-d e-f g-h a-b c-d e-f g-h a-b c-d e-f g-h
1.1 1 2 3 4 25 26 27 28 49 50 51 52 73 74 75 76
1.2 5 6 7 8 29 30 31 32 53
Impurities & Related Compounds: Reference Materials
IMINODIBENZYL
50-04-4
458-37-7
68-41-7
147-94-4
4342-03-4
486-66-8
64-73-3
120013-39-0
54024-22-5
6556-12-3
302776-68-7
20830-75-5
5490-27-7
624-49-7
97-77-8
148408-66
Balancing Histone/Protein Acetylation-Gene Regulation and Cancer Therapy
2
7
teomic identification of protein-protein interactions modu-
lated by specific post-translational modifications.
References
1. Wolffe, A.P. and Matzke, M.A., Science, 286, 481-486 (1999)
Manganese Superoxide Dismutase (MnSOD) and Histone H2A.X Phosphorylation Assay
H, Iyer AK. Tumor-targeted induction of oxystress for cancer therapy. J Drug
Target. 2007;15:475-486. PMID: 17671894
6. Scandalios JG. Oxidative stress: molecular perception and transduction of signals
XP725 Antibody List Lot 129K4831
Cdk4 C8218 1019 CDK4 M NP_000066.1 y y y
73 CDK5 C6118 1020 CDK5 M NP_001157882.1 y y n/d
159 Cdk6 C8343 1021 CDK6 M NP_001138778.1 ,NP_001250.1 y y y
160 Cdk-7/cak C7089 1022 CDK7 M NP_001790.1 y
XP725 Antibody List Lot 129K4830
Cdk4 C8218 1019 CDK4 M NP_000066.1 y y y
73 CDK5 C6118 1020 CDK5 M NP_001157882.1 y y n/d
159 Cdk6 C8343 1021 CDK6 M NP_001138778.1 ,NP_001250.1 y y y
160 Cdk-7/cak C7089 1022 CDK7 M NP_001790.1 y
XP725 Antibody List Lot 089K4791
Cdk4 C8218 1019 CDK4 M NP_000066.1 y y y
73 CDK5 C6118 1020 CDK5 M NP_001157882.1 y y n/d
159 Cdk6 C8343 1021 CDK6 M NP_001138778.1 ,NP_001250.1 y y y
160 Cdk-7/cak C7089 1022 CDK7 M NP_001790.1 y
XP725 Worksheet for Lot Number 071M4826
1 2 E2F1 E8901
483 3 3 1 3 E2F2 E8776
484 3 3 1 4 E2F2 E8776
485 3 3 1 5 E2F3 E8651
486 3 3 1 6 E2F3 E8651
487 3 3 1 7 E2F4 E8526
488 3 3 1 8 E2F4 E8526
489
List of Antibodies
n/d y
483 Myosin Va M5062 P n/d n/d y
484 Myosin VI M0691 M y y y
485 Myosin VI M5187 P n/d n/d y
486 NBS1 (Nibrin) N9287 M y n/d n/d
487 NBS1 (Nibrin) N3037 P y n/d n/d
488 NBS1 (Nibrin) N3162
XP725 Antibody List
_236444.4,NP_004990.3,NP_001034635.1 M y y y
485 Myosin VI M5187 4646 MYO6 NP_004990.3 P n/d n/d y
486 NBS1 (Nibrin) N9287 4683 NBN NP_002476.2 M y n/d n/d
487 NBS1 (Nibrin) N3037 85482, 27354, 4683 NBN
XP725 Antibody List 013M4793
_236444.4,NP_004990.3,NP_001034635.1 M y y y
485 Myosin VI M5187 4646 MYO6 NP_004990.3 P n/d n/d y
486 NBS1 (Nibrin) N9287 4683 NBN NP_002476.2 M y n/d n/d
487 NBS1 (Nibrin) N3037 85482, 27354, 4683 NBN
MAPK: Antibodies, Proteins, Kits, siRNA and Reagents
200 µg 05-778
RhoE/Rnd3 4 H M WB IC ascites M IgG 200 µL 05-723
RhoG H M WB M IgG 100 µg 04-486
RhoGAP p190 D2D6 H M R Mk WB IP Pur M IgG 200
Halal Certificate
PROPIONATE W393304 C42599 HC-23SIDG90
485. CIS-3-HEXENYL TIGLATE W393118 C44276 HC-23SISF90
486. CIS-4-DECENAL 93%, STABILIZED W326402 B21092 HC-23SIYP97
487. CIS-4-HEPTENAL 98%, FCC, FG W328901
Halal Certificate
PROPIONATE W393304 C42599 HC-22SIQP12
485. CIS-3-HEXENYL TIGLATE W393118 C44276 HC-22SI5712
486. CIS-4-DECENAL 93%, STABILIZED W326402 B21092 HC-22SI8Q19
487. CIS-4-HEPTENAL 98%, FCC, FG W328901